Our Story

Stephen Thompson

Founding Partner & Managing Director - Sydney

Stephen is a founding partner of Brandon Capital.

Before moving to Australia, Stephen was a Director of Apax Partners based in London.  Previously, he fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals.  Earlier, Stephen spent ten years as a research immunologist in London and California.

Stephen is currently a director of Amplificare, OncoRes Medical, Respirion Pharmaceuticals and Vaxxas. Stephen was a former director of Elastagen, (acquired by Allergan in 2018) and Longas Technologies (acquired in 2021).

Stephen has a Bachelor of Science (Honours) from Chelsea College London, a PhD in Immunology from Kings College London and an MBA, specialising in Entrepreneurship, from Imperial College London.  Stephen is a Graduate of the Australian Institute of Company Directors and a former director of the Australian Investment Council (AIC).

Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.